{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-033744","form_type":"8-K","ticker":"CDXS","cik":"0001200375","company_name":"CODEXIS, INC.","filed_at":"2024-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.587035+00:00","generated_at":"2026-06-06T03:06:06.712517+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Codexis secures up to $40M term loan from Innovatus; $30M funded","bullets":["First tranche of $30M funded on Feb 13, 2024; second $10M tranche available on milestones.","Interest-only payments for 36-48 months; floating rate of greater of Prime or 7.50% plus 3.25%.","Term loans mature 5 years from initial funding; secured by substantially all assets.","Issued warrants to Innovatus to purchase 424,028 shares at $2.83 per share, cashless exercise.","Proceeds used for working capital and general business requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-033744","json":"https://secwatch.observer/filing/0001193125-24-033744.json","markdown":"https://secwatch.observer/filing/0001193125-24-033744.md","text":"https://secwatch.observer/filing/0001193125-24-033744.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1200375/000119312524033744/0001193125-24-033744-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1200375/000119312524033744/d787129d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T03:06:06.712517+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8ecb4c5edf4c46cca6c2fe67136c52b4c8114e7b","claim":"CODEXIS, INC. incurred term loan of up to $40.0 million with Innovatus Life Sciences Lending Fund I, LP at the greater of (i) Primate Rate and (ii) 7.50%, plus (b) 3.25% maturing 5th anniversary of the initial funding date.","evidence_excerpt":"Lenders listed on Schedule 1.1 thereto, pursuant to which Innovatus, as a Lender, has agreed to make certain term loans to the Company in the aggregate principal amount of up to $40.0 million (the “Term Loans”). Funding of the first $30.0 million tranche was completed on February 13, 2024. The Company will be eligible to draw on a second tranche of $10.0 million upon","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312524033744/0001193125-24-033744-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"up to $40.0 million"},{"label":"Counterparty","value":"Innovatus Life Sciences Lending Fund I, LP"},{"label":"Rate","value":"the greater of (i) Primate Rate and (ii) 7.50%, plus (b) 3.25%"},{"label":"Maturity","value":"5th anniversary of the initial funding date"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"5bd45438a5ba07026a05344e0dfcb0d4742d5973","claim":"CODEXIS, INC. entered into Loan Agreement with Innovatus Life Sciences Lending Fund I, LP valued at up to $40.0 million (effective 2024-02-13).","evidence_excerpt":"On February 13, 2024, Codexis, Inc. (the “Company”) entered into a loan and security agreement (the “Loan Agreement”) with Innovatus Life Sciences Lending Fund I, LP, a Delaware limited partnership (“Innovatus”) as collateral agent and the Lenders listed on Schedule 1.1 thereto, pursuant to which Innovatus, as a Lender, has agreed to make certain term loans to the Company in the aggregate principal amount of up to $40.0 million (the “Term Loans”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1200375/000119312524033744/0001193125-24-033744-index.htm","confidence":0.98,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Innovatus Life Sciences Lending Fund I, LP"},{"label":"Value","value":"up to $40.0 million"},{"label":"Effective","value":"2024-02-13"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}